Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00972062 · ClinicalTrials.gov registry record · NA
Herbal Therapy for Subcutaneous Injection Site Reactions in Multiple Sclerosis
A NA study, sponsored by University of North Carolina, Charlotte.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT00972062 is a NA study that has completed, run by University of North Carolina, Charlotte. The registered enrollment target is 60 participants.
The verdict
NCT00972062, a NA study, has completed, sponsored by University of North Carolina, Charlotte.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if an herbal over-the-counter cream can decrease skin site reactions in multiple sclerosis patients who currently take either Betaseron, Copaxone or Rebif as their subcutaneous medication for managing their multiple sclerosis. Injection site reactions have been indicated as one of the major reasons for discontinuing treatment with the subcutaneous medications (Betaseron, Copaxone, and Rebif) for multiple sclerosis.
Interventions
- OTHER Placebo Cream
- OTHER Bach's Rescue Remedy Cream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2009-06 |
| Est. Completion | 2010-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00972062
The ClinicalTrials.gov registry entry for NCT00972062 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Charlotte, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Cream is the first listed.
NCT00972062 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00972062 about?
NCT00972062 is a clinical study titled "Herbal Therapy for Subcutaneous Injection Site Reactions in Multiple Sclerosis". The purpose of this study is to determine if an herbal over-the-counter cream can decrease skin site reactions in multiple sclerosis patients who currently take either Betaseron, Copaxone or Rebif as their subcutaneous medication for managing their multiple sclerosis. Injection site reactions have b...
What is the current status of trial NCT00972062?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2009-06. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00972062?
The interventions under investigation include: Placebo Cream (OTHER), Bach's Rescue Remedy Cream (OTHER).
Who is sponsoring clinical trial NCT00972062?
This trial is sponsored by University of North Carolina, Charlotte, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.